methazolamide has been researched along with Alloxan Diabetes in 2 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Li, Y | 1 |
| Yuan, X | 1 |
| Yuan, W | 1 |
| Li, C | 1 |
| Zeng, Y | 1 |
| Lian, Y | 1 |
| Qiu, X | 1 |
| Qin, Y | 1 |
| Zhang, G | 1 |
| Liu, X | 1 |
| Luo, C | 1 |
| Luo, JD | 1 |
| Hou, N | 1 |
| Konstantopoulos, N | 1 |
| Molero, JC | 1 |
| McGee, SL | 1 |
| Spolding, B | 1 |
| Connor, T | 1 |
| de Vries, M | 1 |
| Wanyonyi, S | 1 |
| Fahey, R | 1 |
| Morrison, S | 1 |
| Swinton, C | 1 |
| Jones, S | 1 |
| Cooper, A | 1 |
| Garcia-Guerra, L | 1 |
| Foletta, VC | 1 |
| Krippner, G | 1 |
| Andrikopoulos, S | 1 |
| Walder, KR | 1 |
2 other studies available for methazolamide and Alloxan Diabetes
| Article | Year |
|---|---|
Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Topics: Animals; Axin Protein; beta Catenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dia | 2022 |
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Topics: Animals; Blood Glucose; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Experimental; Glucose Clam | 2012 |